GLP-1RAs, approved for type 2 diabetes (T2DM), enhance incretin signaling to improve postprandial glucose metabolism
When opening a new package or pen, use clean hands to prevent contamination
GLP-1 Explore GLP-1 treatment options with a licensed provider and ongoing support designed around your goals
We often recommend a "consistency over intensity" approachtaking a moderate, highly absorbable dose daily is usually more effective than taking a massive dose occasionally
[DOI] [PubMed] [Google Scholar] 102.Imajo K., Kessoku T., Honda Y., Tomeno W., Ogawa Y., Mawatari H., Fujita K., Yoneda M., Taguri M., Hyogo H., et al
Clinical Trial Insights In a Phase 2 clinical trial published in The New England Journal of Medicine , Retatrutide demonstrated remarkable efficacy: Participants with obesity (without diabetes) experienced up to 24.2% reduction in body weight over 48 weeks, surpassing results seen with existing medications